advertisement

---

Advances in Therapy 14

Showing records 1 to 14 | Display all abstracts in Advances in Therapy

112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Araie M
Advances in Therapy 2023; 40: 4639-4656

---

112052 Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study
Tanito M; Mochiji M
Advances in Therapy 2023; 40: 4907-4918

---

112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Sugiyama K
Advances in Therapy 2023; 40: 4639-4656

---

112052 Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study
Tsutsui A
Advances in Therapy 2023; 40: 4907-4918

---

112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Aso K
Advances in Therapy 2023; 40: 4639-4656

---

112052 Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study
Tsutsui A; Harano A; Harano A; Harano A
Advances in Therapy 2023; 40: 4907-4918

---

112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Kanemoto K
Advances in Therapy 2023; 40: 4639-4656

---

112052 Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study
Harano A; Ichioka S
Advances in Therapy 2023; 40: 4907-4918

---

112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Iwata R
Advances in Therapy 2023; 40: 4639-4656

---

112052 Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study
Takayanagi Y
Advances in Therapy 2023; 40: 4907-4918

---

112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Hollander DA
Advances in Therapy 2023; 40: 4639-4656

---

112052 Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study
Takayanagi Y; Kataoka Y
Advances in Therapy 2023; 40: 4907-4918

---

112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Senchyna M; Kopczynski CC
Advances in Therapy 2023; 40: 4639-4656

---

112052 Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study
Takagi Y; Shii D
Advances in Therapy 2023; 40: 4907-4918

---